Complement of an LSC-based MRD assay to the traditional MFC method for relapse prediction of AML: a prospective study

Affiliations

• ¹ Peking University People's Hospital & Peking University Institute of Hematology, Beijing, China.
• ² People' hospital Peking University, Beijing, China.
• ³ peking university people's hospital, Beijing, China.
• ⁴ Peking University People's Hospital, Peking University Institute of Hematology;National Clinical Research Center for Hematologic Disease;Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
• ⁵ Peking University,People's Hospital, Beijing, China.
• ⁶ People's hospital, hematologic institute of Peking univeristy, duarte, United States.
• ⁷ Peking University,Institute of Hematology, Beijing, China.
• ⁸ Peking University,People's hospital, Beijing, China.
• ⁹ Peking University Insititute of Hematology, Beijing, China.
• ¹⁰ Peking University People's Hosital, Beijing, China.
• ¹¹ Peking University People's Hospital, Beijing, China.
• ¹² Peking University Institute of Hematology.
• ¹³ Institute of Hematology, Peking University, Beijing, China.
• ¹⁴ peking University, Beijing, China.